Login / Signup
Safety of Continuous Neostigmine for the Treatment of Impaired Gastrointestinal Motility in Pediatric Patients.
Jesse Cramer
Inez Pabian
Published in:
The Annals of pharmacotherapy (2020)
Keyphrases
</>
biofilm formation
escherichia coli
cystic fibrosis
replacement therapy